Back to top
more

PetMed Express (PETS)

(Real Time Quote from BATS)

$2.69 USD

2.69
28,527

+0.03 (1.13%)

Updated Sep 24, 2025 12:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 246)

Industry: Internet - Commerce

Zacks News

Zacks Equity Research

Myriad Genetics (MYGN) Beats on Earnings & Revenues in Q2

Myriad Genetics' (MYGN) year over year decline in revenue was in Q2 is disappointing. However, strong demand for GeneSight tests was encouraging.

    Zacks Equity Research

    PetMed Express, Beazer Homes, Taylor Morrison, iRobot and NVIDIA as Zacks Bull and Bear of the Day

    PetMed Express, Beazer Homes, Taylor Morrison, iRobot and NVIDIA as Zacks Bull and Bear of the Day

      Brian Bolan headshot

      Top Stock Picks for the Week of February 5th

      Two Stocks That Have Attractive Qualities for Investors.

        Zacks Equity Research

        LabCorp (LH) Q4 Earnings Beat Estimates, '18 View Promising

        LabCorp's (LH) Covance Drug Development of late begins to gain traction from Chiltern acquisition, strong organic growth and a favorable foreign currency translation.

          Zacks Equity Research

          AmerisourceBergen (ABC) Beats on Q1 Earnings, FY18 View Up

          Strong Growth in Pharmaceutical Distribution Segment and World Courier business drove AmerisourceBergen (ABC) in Q1.

            Zacks Equity Research

            Phibro Animal (PAHC) Beats on Q2 Earnings, Raises Guidance

            Phibro (PAHC) witnesses year-over-year improvement across all segments in Q2.

              Zacks Equity Research

              Becton, Dickinson (BDX) Beats on Q1 Earnings, Guidance Solid

              Strong growth in BD Medical and BD Life sciences segments drove Becton, Dickinson's (BD) top line in Q1.

                Zacks Equity Research

                Top Ranked Growth Stocks to Buy for February 6th

                Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, February 6th:

                  Brian Bolan headshot

                  Bull Of The Day PetMed Express (PETS)

                  A solid earnings report and a lawsuit dismissal could make the shorts turn tail on this stock.

                    Zacks Equity Research

                    athenahealth (ATHN) Tops Earnings & Revenue Estimates in Q4

                    Strong growth in Business and Services segment drove athenahealth's (ATHN) top line in Q4.

                      Zacks Equity Research

                      Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q4

                      Omnicell's (OMCL) year-over-year growth at both the segments in Q4 is encouraging.

                        Zacks Equity Research

                        ABIOMED (ABMD) Beats Earnings and Revenue Estimates in Q3

                        ABIOMED (ABMD) rides high on record revenues from Impella in third-quarter fiscal 2018. The company is also well poised with new accomplishments.

                          Zacks Equity Research

                          Pacific Biosciences (PACB) Q4 Loss Narrows, Consumables Up

                          Pacific Biosciences' (PACB) consumable revenue platform proves a vital growth-driver in Q4. Sales momentum in China remains robust.

                            Zacks Equity Research

                            Edwards Lifesciences (EW) Beats on Q4 Earnings and Revenues

                            Edwards Lifesciences (EW) gains from strength in THVT on continued therapy adoption across all geographies in Q4.

                              Zacks Equity Research

                              Alibaba (BABA) Q3 Earnings Lag Estimates, Revenues Grow Y/Y

                              Alibaba Group Holding Limited (BABA) fiscal third-quarter revenues driven by strong momentum in the company's New Retail strategy and expanding cloud business. Higher expenses hurt profits.

                                Zacks Equity Research

                                Alphabet (GOOGL) Q4 Earnings Miss Estimates, Revenues Beat

                                Alphabet Inc. (GOOGL) delivers strong fourth quarter top line numbers on robust advertising and cloud revenues. However, increased expenditure on new activities impacted profits.

                                  Zacks Equity Research

                                  Quest Diagnostics (DGX) Tops Q4 Earnings, 2018 View Strong

                                  Quest Diagnostics' (DGX) year-over-year revenue improvement in Q4 came on the back of successful execution of its two-point strategy of accelerating growth and driving operational excellence.

                                    Zacks Equity Research

                                    Boston Scientific (BSX) Q4 Earnings In Line, Revenues Top

                                    In Q4, Boston Scientific (BSX) registers balanced growth across all business lines and geographies.

                                      Zacks Equity Research

                                      Conmed (CNMD) Beats Earnings and Revenue Estimates in Q4

                                      Conmed (CNMD) benefits from impressive general surgery performance and enhanced innovation in Q4.

                                        Zacks Equity Research

                                        McKesson (MCK) Beats on Q3 Earnings & Revenues, Ups '18 View

                                        Strong Performance in Distribution Solutions segment drives McKesson (MCK) in Q3. An impressive FY18 outlook instills investor's optimism.

                                          Zacks Equity Research

                                          Baxter (BAX) Beats on Q4 Earnings & Revenues, '18 View Solid

                                          Strong performance in the Hospital Products and Renal Products segments drives Baxter (BAX) in Q4.

                                            Zacks Equity Research

                                            IDEXX Laboratories (IDXX) Beats on Q4 Earnings and Revenues

                                            IDEXX (IDXX) rides high on strength in CAG business in Q4. A raised guidance buoys optimism.

                                              Zacks Equity Research

                                              Zacks.com highlights: PetMed Express, SINOPEC Shangai Petrochemical, NVR, Five Below and Gap

                                              Zacks.com highlights: PetMed Express, SINOPEC Shangai Petrochemical, NVR, Five Below and Gap

                                                Zacks Equity Research

                                                QIAGEN (QGEN) Beats on Q4 Earnings and Revenues, Issues View

                                                QIAGEN's (QGEN) year-over-year growth in Q4 revenues is encouraging. Expansion in operating margin buoys optimism.

                                                  Zacks Equity Research

                                                  Why AWS is Important for Amazon's (AMZN) Earnings in Q4

                                                  Amazon's (AMZN) fourth-quarter 2017 results are likely to benefit from AWS's dominant market position and expanding customer base.